Skip to main content
. 2019 Jun 2;1(7):303–311. doi: 10.1253/circrep.CR-19-0047

Figure 1.

Figure 1.

Goal-based therapeutic algorithm used in the present study for newly diagnosed pulmonary arterial hypertension (PAH). ERA, endothelin receptor antagonist; PDE-5, phosphodiesterase-5; V̇O2, oxygen uptake; WHO FC, World Health Organization functional class.